Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

38

Revenue 2017

Imbruvica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Imbruvica was produced by Johnson & Johnson.

Imbruvica gains expanded use in Europe

Imbruvica gains expanded use in Europe

Rival Calquence receives accelerated review in US. AbbVie and Janssen’s Imbruvica (ibrutinib) has received approval from the European Commission (EC) for two expanded variations to broaden the use of the ... Imbruvica has experienced some heated

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn Analysts have not been overly impressed with the bolt-on acquisitions AbbVie has paid for in recent years; the $21bn it spent acquiring Pharmacyclics and its lymphoma treatment Imbruvica was seen

AZ’s Calquence threatens Imbruvica with new leukaemia data

AZ’s Calquence threatens Imbruvica with new leukaemia data in its market battle with AbbVie/Johnson &Johnson’s Imbruvica. ... That could give Calquence a leg-up as it tries to make inroads against Imbruvica (ibrutinib), which is already approved as a first- and second-line therapy for CLL and a

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger lymphocytic lymphoma (SLL) who have failed or become intolerant to prior treatment with Johnson &Johnson’s Imbruvica (ibrutinib).

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Venclexta plus Gazyva approval adds to non-chemo options in CLL Roche’s marketing partner AbbVie has a stake in a direct rival, Imbruvica, which it co-markets with J&J. ... In January, Imbruvica gained approval in first line treatment in combination with Gazyva, making it the first non-chemo combination in this

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics